5 Recruiting AL Amyloidosis Phase 1 Clinical Trials
Active phase 1 studies for al amyloidosis enrolling across the USA. Verify eligibility and contact site coordinators.
All AL Amyloidosis studiesPhase 1 Studies for AL Amyloidosis
🔵 Active, Not Recruiting Phase1 / Phase2
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
📍 Boston Medical Center — Boston, Massachusetts
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
📍 University of California — Orange, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Early Phase1
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
📍 Vanderbilt Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔